Patents Assigned to Nereus Pharmacuticals, Inc.
  • Patent number: 8129527
    Abstract: Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: March 6, 2012
    Assignee: Nereus Pharmacuticals, Inc.
    Inventors: Michael A. Palladino, George Kenneth Lloyd, Yoshio Hayashi